Internal Server Error

IMU Biosciences - About the company

IMU Biosciences is a series A company based in London (United Kingdom), founded in 2019 by Adam Laing and Tom Hayday. It operates as a Provider of immune discovery platform for precision medicines. IMU Biosciences has raised $53M in funding from Molten Ventures and IQ Capital. The company has 115 active competitors, including 34 funded and 4 that have exited. Its top competitors include companies like Cellworks, Geneyx and ICarbonX.

Company Details

Provider of immune discovery platform for precision medicines. The company uses immune profiling with a proprietary machine learning and Artificial intelligence platform to revolutionize immune-powered precision medicine.
Email ID
*****@imubiosciences.com
Key Metrics
Founded Year
2019
Location
Stage
Series A
Total Funding
$53M in 2 rounds
Latest Funding Round
Ranked
Employee Count
85 as on Sep 30, 2026
Similar Companies
Sign up to download IMU Biosciences' company profile

IMU Biosciences's funding and investors

IMU Biosciences has raised a total funding of $53M over 2 rounds. Its first funding round was on Jan 24, 2024. Its latest funding round was a Series A round on Jun 02, 2026 for $*****. 4 investors participated in its latest round. IMU Biosciences has 6 institutional investors.

Here is the list of recent funding rounds of IMU Biosciences:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 02, 2026
8424384
Series A
5454103
8112717
5990471
1210152
Jan 24, 2024
2288078
Series A
7618256
1889858
lockAccess funding benchmarks and valuations. Sign up today!

IMU Biosciences' founders and board of directors

Founder? Claim Profile
The founders of IMU Biosciences are Adam Laing and Tom Hayday. Adam Laing is the CEO of IMU Biosciences.
Here are the details of IMU Biosciences' key team members:

IMU Biosciences' employee count trend

IMU Biosciences has 85 employees as of Sep 26. Here is IMU Biosciences's employee count trend over the years:
Employee count trend for IMU Biosciences
lockUncover IMU Biosciences' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

IMU Biosciences's Competitors and alternates

Top competitors of IMU Biosciences include Cellworks, Geneyx and ICarbonX. Here is the list of Top 10 competitors of IMU Biosciences, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Cellworks
Cellworks
2005, San Jose (United States), Series B
Developer of a biosimulation platform
$16.5M
67/100
2nd
Logo for Geneyx
Geneyx
2018, Herzliya (Israel), Seed
Provider of a clinical genetics data management platform for hospitals and genetic labs
$10M
57/100
3rd
Logo for IMU Biosciences
IMU Biosciences
2019, London (United Kingdom), Series A
Provider of immune discovery platform for precision medicines
$53M
56/100
4th
Logo for ICarbonX
ICarbonX
2015, Shenzhen (China), Series D
Provider of bioinformatic platforms for health management and drug development
$366M
55/100
5th
Logo for Biostate
Biostate
2023, Houston (United States), Series A
Developer of generative AI based RNAstate research platform to predict future omics states
$16M
53/100
6th
Logo for NeoCura
NeoCura
2017, Changping (China), Series A
Provider of an AI-enabled immunotherapy based tumor diagnostic platform
$38.2M
52/100
7th
Logo for Life Bit
Life Bit
2017, London (United Kingdom), Series B
AI and SaaS-based genomics analysis software for drug development
$70.9M
51/100
8th
Logo for Watershed
Watershed
2019, Sacramento (United States), Series A
Provider of software solution for biological data analysis, discovery, and collaboration
$19.7M
48/100
9th
Logo for Liquid Biosciences
Liquid Biosciences
2017, Aliso Viejo (United States), Series C
Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes
$40.1M
-
48/100
10th
Logo for ROSALIND
ROSALIND
2013, San Diego (United States), Seed
Cloud-based collaborative bioinformatics platform for researchers
$70K
45/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on IMU Biosciences's competitors? Click here to see the top ones

IMU Biosciences's Investments and acquisitions

IMU Biosciences has made no investments or acquisitions yet.

Reports related to IMU Biosciences

Here is the latest report on IMU Biosciences's sector:

News related to IMU Biosciences

Media has covered IMU Biosciences for a total of 7 events in the last 1 year, 2 of them have been about partnerships and 2 about people movement.
•
IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive DirectorGlobeNewswire•Nov 20, 2025•IMU Biosciences
•
IMU Biosciences Announces Formation of Scientific Advisory BoardGlobeNewswire•Nov 13, 2025•IMU Biosciences
•
£11.5m and new chair for MedTech IMU BiosciencesBusinessCloud•Jan 24, 2024•IMU Biosciences, Molten Ventures, Life Extension Ventures, Morressier and 4 others
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about IMU Biosciences

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford